"Dr. Hani Salehi-Had is a vitreo-retinal surgeon specializing in the medical and surgical treatment of diseases of the retina, vitreous, and macula."

During the past decade, Salehi Retina Institute Inc. conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Salehi Retina Institute Inc." #1 collaborator was "Juvenile Diabetes Research Foundation" with 2 trials as a collaborator, "National Eye Institute (NEI)" with 2 trials as a collaborator, "National Institutes of Health (NIH)" with 2 trials as a collaborator, "Roche Pharma AG" with 1 trials as a collaborator and "The Leona M. and Harry B. Helmsley Charitable Trust" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Salehi Retina Institute Inc." are "Diabetic Macular Edema" (3 trials), "Diabetic Retinopathy" (3 trials), "Diabetes Mellitus" (2 trials), "Neovascular Age-related Macular Degeneration" (2 trials) and "Diabetic Macular Edema (DME)" (1 trials). Many other conditions were trialed in "Salehi Retina Institute Inc." in a lesser frequency.

Most popular intervention types in "Salehi Retina Institute Inc." are "Drug" (6 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "UBX1325" (2 trials), "Aflibercept" (1 trials), "Aflibercept 2mg" (1 trials), "Deferred Vitrectomy" (1 trials) and "EYLEA® (aflibercept) Injection 2 mg (0.05mL)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Salehi Retina Institute Inc." are 7 trials for "All" genders.

Currently, there are NaN active trials in "Salehi Retina Institute Inc.". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Salehi Retina Institute Inc., undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Salehi Retina Institute Inc., 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".